Cite
HARVARD Citation
Ang, F. et al. (n.d.). Effects of canagliflozin on cardiovascular and kidney outcomes and mortality in primary and secondary cardiovascular prevention: pooled analysis from the CANVAS program and CREDENCE trial. European heart journal. p. . [Online].